Literature DB >> 11472432

Modulation of HIV transcription by CD8(+) cells is mediated via multiple elements of the long terminal repeat.

D M Maslove1, L W Ni, N C Hawley-Foss, A D Badley, K F Copeland.   

Abstract

HIV replication and LTR-mediated gene expression can be modulated by CD8(+) cells in a cell type-dependent manner. We have previously shown that supernatant fluids of activated CD8(+) cells of HIV-infected individuals suppress long terminal repeat (LTR)-mediated transcription of HIV in T cells while enhancing transcription in monocytic cells. Here, we have examined the effect of culture of T cells and monocytic cells with CD8(+) supernatant fluids, and subsequent binding of transcription factors to the HIV-1 LTR. In transfections using constructs in which NF kappa B or NFAT-1 sites were mutated, the LTR retained the ability to respond positively to culture with CD8 supernatant fluid in monocytic cells. Nuclear extracts prepared from both Jurkat T cells and U38 monocytic cells cultured with CD8(+) cell supernatant fluid demonstrated increased binding to the HIV-1 LTR at an AP-1 site which overlapped the chicken ovalbumin upstream promoter (COUP) site. In monocytic cells, increased binding activity was observed at the NF kappa B sites of the LTR. In contrast, an inhibition in binding at the NF kappa B sites was observed in Jurkat cells. Examination of two NFAT-1 sites revealed enhanced binding at - 260 to - 275 bp in U38 cells which was reduced by cellular activation. PMA and ionomycin-induced binding at a second NFAT-1 site (- 205 to - 216 bp) was abrogated by CD8(+) cell supernatant fluid in T cells. These results, taken together, suggest that factors present in CD8(+) supernatant fluids may act through several sites of the LTR to modulate transcription in a cell type-dependent manner.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11472432      PMCID: PMC1906111          DOI: 10.1046/j.1365-2249.2001.01576.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  49 in total

1.  Enhancement of HIV-1 replication in human macrophages is induced by CD8+ T cell soluble factors.

Authors:  K F Copeland; P J McKay; J J Newton; K L Rosenthal
Journal:  Clin Exp Immunol       Date:  1998-10       Impact factor: 4.330

2.  A quantitative bioassay for HIV-1 based on trans-activation.

Authors:  B K Felber; G N Pavlakis
Journal:  Science       Date:  1988-01-08       Impact factor: 47.728

3.  The Fos complex and Fos-related antigens recognize sequence elements that contain AP-1 binding sites.

Authors:  B R Franza; F J Rauscher; S F Josephs; T Curran
Journal:  Science       Date:  1988-03-04       Impact factor: 47.728

4.  Immunoglobulin gene transcription is activated by downstream sequence elements.

Authors:  C Queen; D Baltimore
Journal:  Cell       Date:  1983-07       Impact factor: 41.582

5.  COUP transcription factor is a member of the steroid receptor superfamily.

Authors:  L H Wang; S Y Tsai; R G Cook; W G Beattie; M J Tsai; B W O'Malley
Journal:  Nature       Date:  1989-07-13       Impact factor: 49.962

6.  Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line.

Authors:  T M Folks; J Justement; A Kinter; C A Dinarello; A S Fauci
Journal:  Science       Date:  1987-11-06       Impact factor: 47.728

7.  An inducible transcription factor activates expression of human immunodeficiency virus in T cells.

Authors:  G Nabel; D Baltimore
Journal:  Nature       Date:  1987 Apr 16-22       Impact factor: 49.962

8.  Activation of the AIDS retrovirus promoter by the cellular transcription factor, Sp1.

Authors:  K A Jones; J T Kadonaga; P A Luciw; R Tjian
Journal:  Science       Date:  1986-05-09       Impact factor: 47.728

9.  A diffusible lymphokine produced by CD8+ T lymphocytes suppresses HIV replication.

Authors:  C M Walker; J A Levy
Journal:  Immunology       Date:  1989-04       Impact factor: 7.397

10.  CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication.

Authors:  C M Walker; D J Moody; D P Stites; J A Levy
Journal:  Science       Date:  1986-12-19       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.